EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC 4.0

Perspectives of Heart Transplant Patients and Providers on Acute Rejection Surveillance: A Mixed‐Methods Study

Hyoungmin Kim iD, Vincenzo Cusi iD, Melissa McLenon iD, Jose Benjamin Cruz Rodriguez iD, Quan M Bui iD, Jennifer Chak iD, Marcus Anthony Urey iD, Justin Cole iD, Rebecca Fielding-Miller iD, Paul J Kim iD

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70438 ↗

At a glance

Journal article in Clinical Transplantation, 2026. Written by Hyoungmin Kim and 9 co-authors. Institution: UC San Diego Health, La Jolla, California, USA. Major MEDLINE topics: Heart Transplantation, Graft Rejection, Health Personnel. Cited 1 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: the Williams College Class of 1966 Career Center for Alumni Sponsored Internship Programs, the National Institutes of Health, NCATS NIH HHS.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Background

Endomyocardial biopsies (EMB) remain the reference standard for detection of acute rejection in heart transplant (HTx) patients. Recent studies evaluating novel noninvasive tests have sparked a renewed discussion in the HTx community about revising acute rejection surveillance policies. However, patient and provider perspectives remain underexplored. This single‐center study examined both HTx patient and provider perspectives on replacing EMBs earlier with noninvasive blood tests.

Methods

We performed semi‐structured interviews with 28 HTx patients to explore their perspectives on replacement of EMBs with donor‐derived cell‐free DNA (dd‐cfDNA) early post‐HTx. We subsequently conducted a survey of 118 HTx patients using self‐administered online questionnaires. We also performed semi‐structured interviews with 18 HTx providers to explore their perspectives. Thematic analysis was performed on interview and open‐ended survey responses using deductive and inductive approaches. Patient quantitative survey responses were analyzed with descriptive statistics.

Results

Our study identified three key themes: patient anxiety related to EMBs, importance of patient‐provider communication, and strong interpersonal trust in providers by HTx patients. Although 78.4% of patients experienced EMB‐related anxiety, they prioritized testing accuracy to ensure “the health of their new heart.” Consequently, patients favored the most accurate testing protocol and trusted providers to make this decision (91.1%). HTx providers raised concerns about the accuracy and safety of noninvasive surveillance testing for high‐risk patients.

Conclusion

HTx patients trusted their providers to determine the most accurate acute rejection surveillance policy. Additionally, our study provides important patient‐centered priorities to guide the implementation of early noninvasive testing into clinical practice. Trial Registration : ClinicalTrials.gov identifier: NCT06414603

Subjects

MeSH terms (MEDLINE)

Heart TransplantationGraft RejectionHealth PersonnelHumansMaleFemaleMiddle AgedFollow-Up StudiesPrognosisAdultSurveys and QuestionnairesAgedGraft Survival

Author keywords

clinical practice guidelinesdonor‐derived cell‐free DNA testendomyocardial biopsyheart transplantpatient perspectives

Authors and institutions

  • UC San Diego Health, La Jolla, California, USA.
  • Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, California, USA.
  • Center on Gender Equity and Health, School of Medicine, University of California San Diego, San Diego, California, USA.
  • Division of Infectious Disease and Global Public Health, School of Medicine, University of California San Diego, San Diego, California, USA.

ORCID profiles: Hyoungmin Kim, Vincenzo Cusi, Melissa McLenon, Jose Benjamin Cruz Rodriguez, Quan M Bui, Jennifer Chak, Marcus Anthony Urey, Justin Cole, Rebecca Fielding-Miller, Paul J Kim

Funding

  • the Williams College Class of 1966 Career Center for Alumni Sponsored Internship Programs
  • the National Institutes of Health
  • NCATS NIH HHS

Cite

APA

Kim, H., Cusi, V., McLenon, M., Rodriguez, J. B. C., Bui, Q. M., Chak, J., Urey, M. A., Cole, J., Fielding-Miller, R., & Kim, P. J. (2026). Perspectives of Heart Transplant Patients and Providers on Acute Rejection Surveillance: A Mixed‐Methods Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70438

Vancouver

Kim H, Cusi V, McLenon M, Rodriguez JBC, Bui QM, Chak J, et al. Perspectives of Heart Transplant Patients and Providers on Acute Rejection Surveillance: A Mixed‐Methods Study. Clinical Transplantation. 2026. doi:10.1111/ctr.70438

BibTeX
@article{Kim2026,
  author = {Kim, Hyoungmin and Cusi, Vincenzo and McLenon, Melissa and Rodriguez, Jose Benjamin Cruz and Bui, Quan M and Chak, Jennifer and Urey, Marcus Anthony and Cole, Justin and Fielding-Miller, Rebecca and Kim, Paul J},
  title = {Perspectives of Heart Transplant Patients and Providers on Acute Rejection Surveillance: A Mixed‐Methods Study},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70438}
}
Start for free →